J Am Chem Soc by Majmudar, Jaimeen D. et al.
Harnessing redox cross-reactivity to profile distinct cysteine 
modifications
Jaimeen D. Majmudar1, Aaron M. Konopko1, Kristin J. Labby1, Christopher T.M.B. Tom2, 
John E. Crellin2, Ashesh Prakash1, and Brent R. Martin1,2,*
1Department of Chemistry, University of Michigan, 930 N. University Ave., Ann Arbor, MI 48109, 
USA
2Program in Chemical Biology, University of Michigan, 930 N. University Ave., Ann Arbor, MI 
48109, USA
Abstract
Cysteine S-nitrosation and S-sulfination are naturally occurring post-translational modifications 
(PTMs) on proteins induced by physiological signals and redox stress. Here we demonstrate that 
sulfinic acids and nitrosothiols react to form a stable thiosulfonate bond, and leverage this 
reactivity using sulfinate-linked probes to enrich and annotate hundreds of endogenous S-
nitrosated proteins. In physiological buffers, sulfinic acids do not react with iodoacetamide or 
disulfides, enabling selective alkylation of free thiols and site-specific analysis of S-nitrosation. In 
parallel, S-nitrosothiol-linked probes enable enrichment and detection of endogenous S-sulfinated 
proteins, confirming that a single sulfinic acid can react with a nitrosothiol to form a thiosulfonate 
linkage. Using this approach, we find that hydrogen peroxide addition increases S-sulfination of 
human DJ-1 (PARK7) at Cys106, whereas Cys46 and Cys53 are fully oxidized to sulfonic acids. 
Comparative gel-based analysis of different mouse tissues reveals distinct profiles for both S-
nitrosation and S-sulfination. Quantitative proteomic analysis demonstrates that both S-nitrosation 
and S-sulfination are widespread, yet exhibit enhanced occupancy on select proteins, including 
thioredoxin, peroxiredoxins, and other validated redox active proteins. Overall, we present a 
direct, bidirectional method to profile select redox cysteine modifications based on the unique 
nucleophilicity of sulfinic acids.
Introduction
The cysteine sulfhydryl group is a key target of redox stress, and depending on the 
abundance and type of redox-active species, is covalently modified to one of a series of 
distinct chemical moieties1. Reactive nitrogen species induce formation of S-nitrosocysteine 
(R-SNO)2, and reactive oxygen species induce reversible disulfides and S-sulfenylcysteine 
(R-SOH), as well as irreversible S-sulfinylcysteine (R-SO2H) and S-sulfonylcysteine (R-
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SO3H)3. Aberrant redox modifications are implicated in the pathology of many diseases, 
including inflammation4, stroke5, and neurodegeneration6.
S-nitrosation (R-SNO) of proteins can reversibly mask functional cysteines or alter protein 
dynamics to affect cellular function in both normal and diseased states7. Cysteine S-
nitrosation is initiated by nitric oxide, which can directly react with cysteine thiyl radicals, 
undergo secondary oxidation and react with cysteine thiolates8, or form through reactions 
with dinitrosyliron complexes9. Importantly, S-nitrosation is reversible, primarily by trans-
nitrosation10 of cellular thiols. S-nitrosation has been extensively profiled using the biotin-
switch assay and its variants11, which captures cysteine residues sensitive to ascorbate 
reduction. This indirect approach relies on the chemical orthogonality of ascorbate, which is 
known to reduce weak disulfides12 and other labile redox modifications13. S-nitrosated 
proteins can also be enriched with organomercury resin, followed by performic acid 
oxidation for release and downstream analysis14. Both methods have been used for large-
scale mass spectrometry profiling of S-nitrosated proteins, both in normal and diseased 
states. While the majority of mass spectrometry proteomics studies focus on the effects of 
nitric oxide donors, more recent analyses have identified nearly 1000 endogenous S-
nitrosated proteins in tissues15. In addition, various S-nitrosothiol selective phosphine-based 
probes have been introduced with significant promise for large-scale proteomic analysis16, 
and have already been demonstrated as selective reagents to label and quantify S-nitrosated 
metabolites17. While each method has contributed important biological revelations regarding 
S-nitrosation, new simplified, non-toxic, direct, and selective approaches remain in high 
demand.
Reactive oxygen species primarily oxidize cysteine to form disulfide bonds, which first 
proceed from a S-sulfenylcysteine (R-SOH) intermediate18. In the absence of a resolving 
thiol, additional oxidation leads to formation of cysteine sulfinic acid (Cys-SO2H)19. S-
sulfination is generally irreversible, with the exception of peroxiredoxins, which employ 
sulfiredoxin to reverse accumulated S-sulfination20. Additionally, S-sulfination of the 
PARK7 (DJ-1) is enigmatically critical for the protein’s redox chaperone activity21. While 
there are no reported methods for mass spectrometry profiling of S-sulfination, recently 
reported substituted aryl-nitroso probes suggest S-sulfination is widespread, and may play a 
broader role in protein structure, redox homeostasis, and cellular regulation22.
Here we explore the cross reactivity of S-sulfination with S-nitrosation, which react to form 
a stable thiosulfonate. Biotin conjugated probes enable reciprocal detection, enrichment, and 
analysis of each redox post-translational modification in cell and tissue homogenates, and 
suggests a broader role for sulfinic acids in redox regulation.
Results and Discussion
Sulfinic acids react selectively with S-nitrosothiols
While exploring the interplay of cysteine post-translational modifications, we identified a 
reported reaction between phenylsulfinic acid and S-nitrosocysteine, leading to thiosulfonate 
formation in physiological buffers at room temperature23. Phenylsulfinic acid reacts rapidly 
with N-acetyl-S-nitrosocysteine methyl ester to yield a thiosulfonate product (Figure 1a). 
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More than 99% of the thiosulfonate product remained after 5 hours at pH ≤ 7, demonstrating 
robust stability in physiological buffers (Figure S1). Moreover, we did not observe any 
additional products formed using a photodiode array detector, suggesting a direct conversion 
of reactants to products.
Thiosulfonates are readily exchangeable with thiols, serving as the basis for the cysteine 
capping agent methyl methanethiosulfonate (MMTS)24. To prevent such exchange, we 
found that sulfinic acids do not react with iodoacetamide (IAM) (Figure 1b and Figure S2a) 
or cysteine (Figure S2b) in aqueous buffers, enabling orthogonal alkylation of thiols without 
perturbing nitrosothiols or sulfinic acids. Interestingly, a large number of reported S-
nitrosation studies alkylate thiols with MMTS25, which releases methylsulfinic acid upon 
reaction with cysteine. Any released methylsulfinic acid may proceed to react with S-
nitrosothiols, potentially reducing S-nitrosation detection26.
Approximately 6–10% of all cellular thiols are oxidized and engaged in a disulfide bonds, 
which can rise to >15% upon oxidative stress27. We find that phenylsulfinic acid does not 
react with biologically relevant disulfides such as cystine (Figure S2c) or activated disulfides 
such as 5,5′-dithiobis-(2-nitrobenzoic acid), DTNB (Figure 1c). However, the highly 
activated disulfide dipyridyldisulfide (aldrithiol) forms an insoluble species when mixed 
with equimolar phenylsulfinic acid, but does partially react overnight in a 50% DMSO/PBS 
solution (data not shown). Finally, we observe no reaction between phenylsulfinic acid and 
benzaldehyde (Figure S2d) or with pyrrolidinone sulfenamide (Figure S3). Overall, sulfinic 
acids do not react with free thiols, biological disulfides, aldehydes or sulfenamides, 
highlighting an unappreciated chemoselective reaction with S-nitrosothiols. Furthermore, 
after initial iodoacetamide alkylation of free thiols, sulfinic acid probes could be leveraged to 
label and enrich S-nitrosothiols for analysis.
Reaction analysis
To characterize the reaction of nitrosothiols and sulfinic acids, we assayed thiosulfonate 
formation by measuring the loss of S-nitroso-glutathione (GSNO) absorbance at 340 nm 
after phenylsulfinic acid addition (Figure S4). Increasing amounts of sodium phenylsulfinate 
were titrated to a 2 mM solution of S-nitrosoglutathione in the dark. The reported pKa of a 
sulfinic acid is ~2.828, yet the reaction proceeds similarly at pH 1, suggesting the sulfur lone 
pair acts as the nucleophile, independent of the protonation state. Sulfinic acids are ambident 
nucleophiles29, where the soft sulfur atom is the attacking species, and the oxygen charge 
state should not significantly affect sulfur nucleophilicity. At pH 1, 4, and 7, the reaction rate 
is approximately first order and proceeds at 3 x 10−2 M−1s−1. At neutral pH, the 
concentration dependence is slightly hyperbolic, suggesting a small contribution from an 
alternate reaction mechanism, and no reaction occurs under basic conditions.
A potential reaction mechanism was recently reported requiring two sulfinic acids; one to 
attack the nitrogen of the nitrosothiol, and a second sulfinic acid to react with the sulfur to 
displace N-hydroxysulfonamide and the thiosulfonate in stoichiometric amounts30. This is in 
contrast to our initial reaction analysis, which did not reveal any additional products. 
Standard curves were then derived from isolated chemical standards to allow detailed 
analysis of the reaction between sodium 4-methyl-phenyl sulfinate and GSNO (Figure S5a–
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d). This analysis reveals sub-stoichiometric formation of N-hydroxybenzenesulfonamide, 
which is only detected in the presence of significant excess sulfinic acid (Figure 2b), and 
thus not in our initial near-stoichiometric HPLC analysis.
N-hydroxysulfonamides are prone to degradation at higher pH, decomposing to release 
sulfinic acid and nitroxyl (HNO)31. To investigate whether the sub-stoichiometric formation 
of the N-hydroxysulfonamide product can be attributed to loss through degradation, we 
assayed the stability of N-hydroxy-4-methylbenzenesulfonamide at pH 1, 4, 7 and 10 
(Figure S5e). Our findings demonstrate that N-hydroxy-4-methylbenzenesulfonamide is 
stable at pH 1, and degrades slowly at pH 4. At pH 7, N-hydroxy-4-
methylbenzenesulfonamide decomposes with a half-life of ~4 hours. Furthermore, since the 
decomposition of N-hydroxy-4-methylbenzenesulfonamide generates nitroxyl and a sulfinic 
acid, excess sulfinic acid will slow decomposition by mass action32. After taking 
degradation into account, N-hydroxysulfonamide formation is not stoichiometric with 
formation of the thiosulfonate product. Overall, the reaction between sulfinic acids and 
nitrosothiols proceeds by an alternative mechanism without concomitant N-
hydroxysulfonamide formation.
Biotin-SO2H detects S-nitrosated proteins
Next, we examined the reactivity of reporter linked sulfinic acids with S-nitrosated proteins. 
Biotin and fluorescein N-hydroxysuccinimide (NHS) esters were directly coupled to the 
sulfinic acid metabolite hypotaurine (Biotin-SO2H) or the sulfonic acid metabolite taurine 
(Biotin-SO3H) in de-gassed water, purified by preparative HPLC, and stored in single-use 
aliquots at −80 °C to prevent oxidation. Biotin-SO2H is stable during the duration of 
labeling (< 1 hour), but is fully oxidized to biotin-SO3H after ~5 hours in atmospheric 
oxygen.
Each probe was incubated with mammalian cell lysates denatured in 6 M urea in phosphate-
buffered saline (PBS), pre-alkylated with excess iodoacetamide, and analyzed by non-
reducing SDS-PAGE and streptavidin-Cy5 blot detection. Biotin-SO2H, but not biotin-
SO3H, labeled a rich profile of proteins (Figure 3a), confirming the reaction is dependent on 
the nucleophilic sulfinic acid. Biotin-SO2H labeling is enhanced at higher probe 
concentrations (Figure S6a) or by pre-incubation with the nitric oxide donor methylamine 
hexamethylene me-thylamine NONOate (MAHMA-NONOate) (t1/2 = 3 min) (Figure 3b and 
S6b). Furthermore, labeling is eliminated by pretreatment with excess hypotaurine (Figure 
S6c), demonstrating saturated labeling above 5 mM. In addition, 365 nm ultraviolet 
photolysis of S-nitrosothiols or pretreatment with ascorbate eliminates biotin-SO2H labeling 
(Figure 3c–d). Importantly, all biotin-SO2H labeling is all labeling is thiol-dependent, and 
reversed by post-incubation with tris(2-carboxyethyl)phosphine (TCEP).
Sulfenic acids (R-SOH) describe the meta-stable oxidation of thiols to a highly reactive 
intermediate, which are typically resolved by a secondary thiol during disulfide 
formation18a, 33. Based on the electrophilic nature of sulfenic acids, we next examined if 
sulfinic acids react with sulfenic acids. The sulfenic acid sensitive probe dimedone is widely 
used to covalently trap sulfenic acids in complex proteomes and in living systems3, 34. In 
order to explore this potential cross-reactivity, we found that standard working 
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concentrations of dimedone had no effect on biotin-SO2H labeling in cell lysates, 
confirming dimedone does not significantly interfere with S-nitrosothiols. Interestingly, 
dimedone-alkyne labeling was largely eliminated after denaturing proteins in 6 M urea. 
Thus, the denaturing biotin-SO2H assay conditions remove any sulfenic acids, limiting any 
concerns about cross-reactivity. In addition, ascorbate eliminates nearly all dimedone 
labeling, providing further evidence in the absence of denaturing buffers, sulfenic acids may 
also be analyzed when using the biotin-switch method for detecting S-nitrosation. In 
addition, sodium meta-arsenite has been reported as a selective sulfenic acid reductant35. We 
do not observe any arsenite-dependent effects on biotin-SO2H labeling (Figure S7), 
providing further support for orthogonal labeling between sulfinic acids and nitrosothiols.
The common alkylating agent, methyl methane thiosulfonate (MMTS) reacts with free thiols 
to form a disulfide bond, releasing methane sulfinic acid. Surprisingly, if we block thiols 
with MMTS instead of iodoacetamide, we observe a complete loss in biotin-SO2H labeling 
(Figure 3h and Figure S8a). Based on this analysis, sufficient methyl sulfinic acid is released 
through MMTS alkylation of thiols to react with nitro-sothiols26. This effect could similarly 
be caused by trans-nitrosation between thiol contaminants formed through slow 
disproportionation of sulfinic acids36. This is unlikely, since removing MMTS prior to 
biotin-SO2H does not restore labeling (Figure S8b). These findings warrant a careful 
reinterpretation of the biotin-switch S-nitrosation enrichment method, which typically 
begins with MMTS alkylation of free thiols. Once nitrosothiols react with methyl sulfinic 
acid, the resulting thiosulfonate can be slowly reduced by ascorbate, liberating a free thiol 
for further enrichment. Overall, iodoacetamide effectively blocks all thiols in our 
experiments, as well as sites of persulfidation37, providing a robust platform for the 
detection of endogenous S-nitrosothiols.
Next, biotin-SO2H was used to profile the S-nitrosation of purified recombinant human 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a known S-nitrosated protein38. 
GAPDH was dissolved in PBS and then treated under different conditions, followed by 
incubation with iodoacetamide and biotin-SO2H to primarily evaluate the specificity of 
sulfinic acid probes for nitrosothiols using a purified protein. As expected, no S-nitrosation 
was observed until treatment with MAHMA NONOate, which was reduced by ascorbate 
pre-treatment (Figure 4a). S-nitroso-glutathione (GSNO) is reported to S-nitrosate GAPDH 
via trans-nitrosation10. GAPDH is only labeled by biotin-SO2H after GSNO addition. 
Labeling is reversed by incubation with dithiothreitol, which cleaves the thiosulfonate 
linkage (Figure 4b). Further high-resolution mass spectrometry analysis of denatured and 
labeled GAPDH tryptic peptides confirmed thiosulfonate formation (Figure S9).
Biotin-GSNO detects S-sulfinated proteins
We next asked what would happen if we reversed our detection scheme, by applying S-
nitrosothiol-linked probes to detect endogenous S-sulfination. Similar reactivity was recently 
reported using an aryl-nitroso probe for conjugation to sulfinic acid standards to form a 
stable N-sulfonylbenzisoxazolone22. While both approaches use nitroso moieties to react 
with sulfinic acids, each follow different mechanistic pathways.
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Accordingly, biotin-GSNO was synthesized in one step from biotin-NHS and GSNO in de-
gassed phosphate buffer in the dark. After HPLC purification, the probe was stored as 
single-use aliquots at −80 °C to minimize formation of oxidized biotin-GSSG-biotin, or used 
immediately for best results. Mammalian cell lysates were first denatured in 6 M urea in 
PBS, and treated with dithiothreitol (DTT) to reduce disulfides (Figure S10) without 
affecting sulfinic acids21a, 39. This is essential as to prevent exchange with any de-nitrosated 
glutathione in the probe stock. The reduced lysate was then incubated with iodoacetamide to 
block free thiols, and precipitated to remove any residual reactants. After solubilization in 6 
M urea, biotin-GSNO was added to label S-sulfinated proteins for gel-based analysis. 
Labeling is not affected by pretreatment with S-methyl glutathione (Figure 5a), but 
competed by excess GSNO (Figure 5b). Together, these controls confirm nitrosothiol-
dependent labeling of iodoacetamide resistant protein modifications with no bias towards 
specific sites. Similarly, dimedone had no effect on biotin-GSNO labeling, confirming there 
is no cross reactivity with thiosulfonates, sulfinic acids, or that any residual sulfenic acids 
are present after denaturation (Figure 5c). Additionally, all labeling is eliminated by post-
incubation with TCEP, which reduces the thiosulfonate product (Figure 5d). Pretreatment of 
iodoacetamide labeled lysates with hydrogen peroxide (50 mM) prevented any reaction with 
biotin-GSNO, presumably by oxidizing sulfinic acids to sulfonic acids (Figure 5e). Finally, 
oxidized glutathione (GSSG) was coupled to biotin-NHS to examine if any non-specific 
labeling occurred by disulfide exchange. Even though disulfides are reduced and alkylated at 
the beginning of the assay, incomplete alkylation could lead to significant false positives if 
the biotin-GSNO probe decomposes to the oxidized disulfide. Under these assay conditions, 
biotin-GSSG does not label any proteins (Figure 5f), confirming selective conjugation of 
between nitrosothiols and sulfinic acids is selective and bidirectional.
The redox chaperone DJ-1 (PARK7) readily forms a stable sulfinic acid at Cys10621a, 21d, 
which is critical for suppressing redox stress21b. DJ-1 also reduces nitrosative 
stress21b, 21c, 40, suggesting that oxidized DJ-1 may react directly with cellular nitrosothiols 
forming a thiosulfonate, which is readily reduced by cellular thiols like glutathione. Here, 
we demonstrate that under non-denaturing oxidative conditions, DJ-1 reacts with N-acetyl-
S-nitrosocysteine methyl ester and GSNO (Figure 6). After peroxide and iodoacetamide 
treatment, native DJ-1 was incubated with N-acetyl-S-nitrosocysteine methyl ester and 
digested with trypsin for high-resolution LC-MS analysis. High resolution MS/MS analysis 
unambiguously confirmed thiosulfonate formation at Cys106 (Figure S11). Furthermore, 
peptides lacking a cysteine were unaffected by up to 200 mM peroxide treatment. In the 
absence of peroxide, DJ-1 Cys106 is fully alkylated by iodoacetamide and no labeling with 
GSNO is detectable. After incubation with 10 mM peroxide, Cys106 is detected primarily as 
the thiosulfonate conjugate, with partial conversion to the unreactive sulfonic acid. 
Oxidation is further enhanced after treatment with 200 mM peroxide, which eliminates all 
Cys106-SO2H and prevents thiosulfonate formation. Both Cys46 and Cys53 did not react 
with GSNO after peroxide treatment, as they were directly converted to the unreactive 
sulfonic acid.
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Profiling native S-nitrosation and S-sulfination
Immortalized mammalian cell lines are adapted to atmospheric oxygen, potentially 
augmenting the profile of oxidative modifications. Therefore, we isolated mouse tissues for 
immediate processing and gel-based analysis. Surprisingly, we detect defined tissue-specific 
patterns of both S-nitrosation (Figure 7a) and S-sulfination (Figure 7b), demonstrating 
orthogonal protein targets of each modification in vivo.
To annotate the endogenous targets of each redox modification in cells, both biotin-SO2H 
and biotin-GSNO conjugates were profiled using stable-isotope labeling with amino acids in 
cell culture (SILAC) for quantitative mass spectrometry proteomics. For profiling S-
nitrosation, heavy or light cell 293T cell pellets were lysed by sonication in 6 M urea, treated 
with excess iodoacetamide, and incubated with either biotin-SO2H or biotin-SO3H. After 
chloroform/methanol precipitation, the two proteomes were combined for streptavidin 
enrichment, trypsin digestion, and high resolution mass spectrometry analysis. Through a 
combination of 4 biological replicates, each with 2 technical replicates, a total of 992 
proteins were identified with SILAC ratios > 5 (biotin-SO2H/biotin-SO3H), quantified in ≥ 3 
replicates, and represented by ≥ 3 quantified peptides (Table S1). After elution of tryptic 
peptides, resin-bound biotinylated peptides were eluted with TCEP and alkylated with 
maleimide, enabling detection of an additional 98 sites of S-nitrosation by mass 
spectrometry (Table S2). These lists include nearly all previously annotated S-nitrosated 
proteins, including ion channels, chaperones, peroxiredoxins, p53, HDACs, hundreds of 
metabolic enzymes, as well as a rich set of novel proteins.
To profile S-sulfination, heavy or light cell 293T cell lysates were separately treated with 
DTT, alkylated with excess iodoacetamide, and treated with either biotin-GSNO or free 
biotin. After enrichment and mass spectrometry analysis, nearly 300 S-sulfinated proteins 
were specifically enriched, including DJ-1 (PARK7), phosphatases, metabolic enzymes, and 
a partially overlapping set of oxidized proteins (Table S3). Resin-bound peptides were eluted 
using TCEP reduction, enabling identification of an additional 30 specific sites of S-
sulfination (Table S4), altogether providing the first large-scale analysis of this redox 
modification.
Next, to evaluate the relative occupancy of each redox modification, we quantified both S-
nitrosation and S-sulfination enrichment in comparison with relative protein abundance. 
Unenriched 293T proteomes were analyzed using label-free quantification (Table S5)41 
based on the integrated ion intensity of the top 3 most intense ions for each protein. 
Individual protein values from the probe enrichment were divided by their corresponding 
relative abundance, providing a distribution of ratios reflecting proportionally higher 
modification occupancy (Figure 8a and Table S6). This analysis is critical to identify not just 
abundant proteins with fractional oxidation, but to highlight proteins with greater 
representative modification occupancy. Importantly, this is not an absolute stoichiometry. 
This value reflects the relative enrichment efficiency as compared to the estimated relative 
abundance, and helps identify proteins that may be low abundance, but are highly modified.
For both redox modifications, the majority of proteins were observed with low ratios, 
signifying poor relative enrichment and low modification stoichiometry characteristic of 
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abundant proteins, including several heat shock, cytoskeletal, and ribosomal proteins. In 
contrast, S-nitrosated proteins with large ratios signify high relative occupancy, including 
several metabolic enzymes and proteins with metal coordination sites, such as HDAC1 and 
carbonic anhydrase. Interestingly, S-sulfinated proteins with large ratios include validated 
oxidation prone enzymes such as peroxiredoxins, thioredoxin, pyruvate kinase, and 
triosephosphate isomerase. Approximately 175 proteins were selectively enriched with both 
probes, revealing inherent preferences for each redox modification (Figure 8b). Interestingly, 
DJ-1 was found to be both S-nitrosated and S-sulfinated. Both Cys46 and C53 are surface 
exposed and established sites of S-nitrosation42 and the tryptic peptide containing Cys53 
was identified in our endogenous site-specific analysis. In contrast, Cys106 is primarily S-
sulfinated21a, 21b, 21d, demonstrating how a single endogenous protein can harbor more than 
one distinct redox modifications.
Conclusions
Overall, this approach highlights proteins with enhanced susceptibility to distinct redox 
modifications, opening new opportunities for multiplexed profiling of disease-dependent 
mutually competitive cysteine modifications. This simplified, direct approach bypasses the 
hazards of mercury-based affinity reagents, and avoids complex disulfide chemistry 
commonly used for ascorbate-dependent reduction strategies. While the thiosulfonate 
linkage is not ideal for stable enrichment, we find that after proper alkylation of free thiols, 
thiosulfonates are sufficiently stable for non-reducing gel-based analysis and mass 
spectrometry profiling. Importantly, these findings establish that sulfinic acids possess 
intrinsic reactivity that may contribute to cellular redox regulation. As observed for human 
DJ-1, once Cys106 is oxidized to a sulfinic acid, it readily converts S-nitrosated thiols to an 
easily exchangeable thiosulfonate. Future studies will explore if enzymes, once exposed to 
oxidative stress, form nucleophilic sulfinic acids that aid cells from accumulating further 
oxidative damage.
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Figure 1. 
Sulfinic acid reactivity in phosphate buffer. (a) Phenylsulfinic acid (2, 20 mM) reacts with 
N-acetyl S-nitroso cysteine methyl ester (1, 5 mM) to form thiosulfonate 3. Absorbance was 
measured at 283 nm. (b) No additional peaks are observed when phenylsulfinic acid is 
incubated with iodoacetamide in PBS for 30 minutes. Absorbance was measured at 291 nm. 
(c) Phenylsulfinic acid, 2, does not react with the activated disulfide DTNB, 5. Absorbance 
was measured at 291 nm for phenylsulfinic acid and 265 nm for DTNB and the reaction 
mixture.
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Figure 2. 
Reaction kinetics and by-product analysis. (a) Reaction rate between phenylsulfinic acid and 
GSNO at various pHs. (b) Percent yield of the thiosulfonate product and the 4-methyl-
Piloty’s acid product.
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Figure 3. 
Sulfinic acid probes selectively label S-nitrosothiols in HEK293T cell lysates. Unless 
otherwise noted, all lysates are denatured in 6 M urea supplemented with 50 mM 
iodoacetamide (IAM). (a) Biotin-SO2H, but not biotin-SO3H, labels S-nitrosothiols in 
lysates. (b) Biotin-SO2H labeling increases following pre-treatment with MAHMA 
NONOate, a nitric oxide donor before IAM addition. (c) UV photolysis (365 nm) pre-
treatment eliminates biotin-SO2H labeling. (d) Biotin-SO2H labeling is eliminated by pre-
treatment with ascorbate. (e) The products of biotin-SO2H labeling are sensitive to post-
treatment by the reductant TCEP. (f) The sulfenic acids probe dimedone does not reduce 
biotin-SO2H labeling. (g) Denaturing buffers or ascorbate reduce dimedone-alkyne labeling 
of sulfenic acids. Following a 1 hour incubation with dimedone alkyne, lysates were 
chloroform/methanol precipitated and mixed with TBTA, CuSO4, TCEP, and TAMRA-azide 
for 1 hour in PBS before gel analysis. (h) MMTS and IAM both react with free thiols, but 
MMTS liberates methane sulfinic acid and interferes biotin-SO2H labeling of S-nitrosated 
proteins.
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Figure 4. 
Labeling of recombinant human GAPDH with biotin-SO2H. (a) GAPDH labeling is 
observed only in the presence of MAHMA NONOate, and eliminated by pre-treatment with 
ascorbate. (b) GAPDH is labeled by the trans-nitrosation donor GSNO, and eliminated by 
pre-treatment with the reducing agent DTT.
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Figure 5. 
Biotin-GSNO (1 mM) labels a unique profile of S-sulfinated proteins in HEK293T cell 
lysates. (a) Biotin-GSNO labeling is not competed by S-methylglutathione (1 mM). (b) 
GSNO competes with biotin-GSNO for labeling native S-sulfinated proteins. (c) Biotin-
GSNO labeling of S-sulfination is unaffected by dimedone (1 mM). (d) Proteins first labeled 
with biotin-GSNO are then lost after TCEP (5 mM) addition. (e) Peroxide pre-treatment in 
iodoacetamide alkylated lysates eliminates biotin-GSNO labeling, suggesting terminal 
oxidation of sulfinic acids to non-reactive sulfonic acids. (f) Biotin-GSSG, a putative 
contaminant in biotin-GSNO, does not label any proteins.
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Figure 6. 
Analysis of thiosulfonate formation on recombinant human DJ-1. Purified, recombinant 
DJ-1 was treated with buffer, 10 mM hydrogen peroxide, or 200 mM peroxide. Samples 
were treated with iodoacetamide (IAM) to block free thiols, and excess reagents were 
removed by gel filtration before incubating with GSNO. The relative abundance of each of 
the modified peptide was measured by mass spetrometry of trypic peptides. The peptide 
abundances were normalized to reflect relative changes within each condition. Error bars 
represent standard deviations of from three replicates. The control peptide E64–K89 showed 
no peroxide-dependent changes.
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Figure 7. 
Profiling native S-nitrosation and S-sulfination in mouse tissues. (a) S-nitrosation profile of 
mouse tissues labeled with biotin-SO2H. (b) S-sulfination profile of mouse tissues labeled 
with biotin-GSNO using matched protein loading, fluorescence detection, and image 
settings.
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Figure 8. 
Relative comparative protein-level occupancy of redox modifications. (a) Histogram of 
calculated relative occupancy ratios of S-nitrosated proteins (left) compared to S-sulfinated 
proteins (right), derived from label-free quantiation. (b) Comparative analysis of relative 
occupancy ratios of both S-nitrosated and S-sulfinated proteins reveals inherent preferences 
towards each redox modification. Arbitrary lines and color boundaries are presented, 
separating abundant, low occupancy proteins (grey), from highly S-nitrosated (blue), highly 
S-sulfinated (green), and proteins with enhanced occupancy for each modification (red).
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